Technical Analysis for CBPO - China Biologic Products, Inc.

Grade Last Price % Change Price Change
grade B 94.5 1.35% 1.26
CBPO closed up 1.35 percent on Tuesday, July 23, 2019, on 84 percent of normal volume.

Earnings due: Aug 2

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical CBPO trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Bollinger Band Squeeze Range Contraction 1.35%
NR7 Range Contraction 1.35%
Lower Bollinger Band Walk Weakness 1.35%
50 DMA Support Bullish 1.61%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.61%
Bollinger Band Squeeze Range Contraction 1.61%
BB Squeeze + Lower Band Touch Range Contraction 1.61%
Lower Bollinger Band Touch Weakness 1.61%

Older signals for CBPO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
China Biologic Products, Inc., a biopharmaceutical company, through its subsidiaries, engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also offers human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human albumin and human immunoglobulin for intravenous injection (IVIG) products for original immunoglobulin deficiency, secondary immunoglobulin deficiency, and auto-immune deficiency diseases; and Thymopolypeptides injection that is used for the treatment of various original and secondary T-cell deficiency syndromes, auto-immune deficiency diseases, and a range of cell immunity deficiency diseases, as well as assists in the treatment for tumors. In addition, it provides human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; human tetanus immunoglobulin for the prevention and therapy of tetanus; and placenta polypeptide that is used for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia caused by various reasons, as well as assists in postoperative heating. The company's products under development comprise human prothrombin complex concentrate; human hepatitis B immunoglobulin (PH4) for intravenous injection; human fibrinogen; Varicella hyperimmune globulins; and Human IVIG. It distributes its products directly or through distributors. The company is based in Beijing, the People's Republic of China.
Medicine Biopharmaceutical Immunology Antibodies Immune System Tumors Glycoproteins Rabies Hydrocephalus Immunoglobulin Therapy Measles Shock Tetanus Varicella
Is CBPO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 105.5
52 Week Low 60.08
Average Volume 138,931
200-Day Moving Average 84.1371
50-Day Moving Average 92.6854
20-Day Moving Average 94.24
10-Day Moving Average 93.547
Average True Range 1.757
ADX 16.99
+DI 19.4763
-DI 17.108
Chandelier Exit (Long, 3 ATRs ) 91.729
Chandelier Exit (Short, 3 ATRs ) 97.51099999999999
Upper Bollinger Band 95.9881
Lower Bollinger Band 92.4919
Percent B (%b) 0.57
BandWidth 3.70989
MACD Line 0.1012
MACD Signal Line 0.2267
MACD Histogram -0.1255
Fundamentals Value
Market Cap 2.57 Billion
Num Shares 27.2 Million
EPS 3.84
Price-to-Earnings (P/E) Ratio 24.61
Price-to-Sales 6.40
Price-to-Book 4.00
PEG Ratio 1.53
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 97.37
Resistance 3 (R3) 97.38 96.44 96.89
Resistance 2 (R2) 96.44 95.71 96.43 96.73
Resistance 1 (R1) 95.47 95.26 95.96 95.46 96.57
Pivot Point 94.53 94.53 94.77 94.52 94.53
Support 1 (S1) 93.56 93.80 94.05 93.55 92.43
Support 2 (S2) 92.62 93.35 92.61 92.27
Support 3 (S3) 91.65 92.62 92.11
Support 4 (S4) 91.64